PeptideWeight loss

Cagrilintide

Also called CagriSema

A long-acting amylin analogue for weight loss, tested with semaglutide as CagriSema.

Usual amount
0.3–2.4 mg
commonly reported
How it’s taken
Injection under the skin
Half-life
about 7 days
half of it gone after
Good after mixing
28 days
in the fridge
Track this in StackbaseFree. Your doses, streaks and supplies in one private place.

What it is

Cagrilintide copies amylin, a hormone released together with insulin that makes you feel full. It lasts about a week. On its own it led to around 10% weight loss in a phase 2 trial; combined with semaglutide (CagriSema) the results were larger. It is not approved yet.

How it’s used

  • Injected under the skin once a week, often alongside semaglutide, with slow dose increases.

Typical amounts

  • Trials used 0.16 to 4.5 mg a week. CagriSema pairs 2.4 mg of cagrilintide with 2.4 mg of semaglutide.

Good to know

  • Not approved; products sold now are unregulated.
  • Nausea, constipation and tiredness are common at the start.

Educational information, not medical advice. Check anything you take with a doctor or pharmacist.